Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 12, 2021

SELL
$138.17 - $184.34 $680,625 - $908,058
-4,926 Closed
0 $0
Q3 2020

Nov 13, 2020

BUY
$114.09 - $145.51 $562,007 - $716,782
4,926 New
4,926 $686,000

Others Institutions Holding NVRO

About NEVRO CORP


  • Ticker NVRO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,387,800
  • Market Cap $133M
  • Description
  • Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...
More about NVRO
Track This Portfolio

Track Blue Rock Advisors, LLC Portfolio

Follow Blue Rock Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blue Rock Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Blue Rock Advisors, LLC with notifications on news.